KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $30.0 million.

  • Elevance Health's Share-based Compensation rose 20344.83% to $30.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $276.0 million, marking a year-over-year increase of 4450.26%. This contributed to the annual value of $276.0 million for FY2025, which is 4450.26% up from last year.
  • According to the latest figures from Q4 2025, Elevance Health's Share-based Compensation is $30.0 million, which was up 20344.83% from $84.0 million recorded in Q3 2025.
  • Elevance Health's Share-based Compensation's 5-year high stood at $92.0 million during Q2 2024, with a 5-year trough of -$29.0 million in Q4 2024.
  • Moreover, its 5-year median value for Share-based Compensation was $69.0 million (2021), whereas its average is $63.8 million.
  • Per our database at Business Quant, Elevance Health's Share-based Compensation tumbled by 14027.78% in 2024 and then soared by 20344.83% in 2025.
  • Elevance Health's Share-based Compensation (Quarter) stood at $59.0 million in 2021, then grew by 23.73% to $73.0 million in 2022, then dropped by 1.37% to $72.0 million in 2023, then crashed by 140.28% to -$29.0 million in 2024, then skyrocketed by 203.45% to $30.0 million in 2025.
  • Its last three reported values are $30.0 million in Q4 2025, $84.0 million for Q3 2025, and $81.0 million during Q2 2025.